The Rheumatologist
You are here: Home / Articles / New Treatment Guidelines to Be Presented at the 2016 ACR/ARHP Annual Meeting

New Treatment Guidelines to Be Presented at the 2016 ACR/ARHP Annual Meeting

• By

Two sets of guidelines—one on managing anti-rheumatic drugs perioperatively for patients undergoing total hip and knee replacements, and another that updates glucocorticoid-induced osteoporosis prevention and treatment strategies—will be featured in sessions at the 2016 ACR/ARHP Annual Meeting this month.

The Sessions
Sunday, Nov. 13, 2:30–3:30 p.m.: Glucocorticoid-Induced Osteoporosis Prevention and Treatment: A New ACR Clinical Guideline

  • Monday, Nov. 14, 9:00–10:00 a.m.: Perioperative Management of Anti-Rheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Knee Arthroplasty: A New ACR/AAHKS Clinical Guideline

Perioperative Management Guideline

Key Points & Current Status

Pages: First |1 | 2 | 3 | ... | Next → | Last | Single Page

Leave a Reply

Your email address will not be published. Required fields are marked *

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »